The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer

Jie Mei(Nanjing Medical University), Yan Zhang(Union Hospital)

British Journal of Cancer

September 15, 2023

10.1038/s41416-023-02432-6

Cited by 13

Related Papers

Neuronal Induction of Bone‐Fat Imbalance through Osteocyte Neuropeptide Y

|Advanced Science|2021|106

A DAAM1 3′-UTR SNP mutation regulates breast cancer metastasis through affecting miR-208a-5p-DAAM1-RhoA axis

|Cancer Cell International|2019|46

SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers

|iScience|2023|21

Linc00941 regulates esophageal squamous cell carcinoma via functioning as a competing endogenous RNA for miR-877-3p to modulate PMEPA1 expression

|Aging|2021|18